Helicobacter pylori and stomach cancer: A case-control study in Venezuela

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 9, 2000, Pages 961-965

  Plummer, M ^a   Vivas, J ^a   Fauchere, J L ^a   Del Giudice, G ^a   Pena, A S ^a   Ponzetto, A ^a   Lopez, G ^a   Miki, K ^a   Oliver, W ^a   Munoz, N ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; STOMACH CANCER; STRAIN DIFFERENCE; VENEZUELA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGE; PEPSINOGEN A; PREVALENCE; SPECIES SPECIFICITY; STOMACH NEOPLASMS; VENEZUELA;

EID: 0033801181     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Estimates of the worldwide mortality from twenty-five major cancers in 1990
2. A human model of gastric carcinogenesis
3. Seroepidemiology of Campylobacter pylori infection in various populations
4. Stomach cancer among Japanese in Hawaii
5. Symptoms and risk factors of Helicobacter priori infection in a cohort of epidemiologists
6. The cohort effect and Helicobacter pylori
7. Helicobacter pylori and the birth cohort effect: Evidence of a continuous decrease of infection rates in childhood
8. The decline in gastric cancer: Epidemiology of an unplanned triumph
9. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease
10. Is Helicobacter pylori a cause of gastric neoplasia?
11. Helicobacter pylori and gastric cancer
12. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
13. Diagnosis of Helicobacter pylori infection in a developing country: Comparisons of two ELISAs and a seroprevalence survey
14. Comparison of two enzyme-linked immunoabsorbant assay tests for diagnosis of Helicobacter pylori infection in China
15. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification
16. Seroconversion for Helicobacter pylori
17. Evaluation of a commercial ELISA kit for the serological diagnosis of Helicobacter pylori infection
18. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori
19. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders
20. Serum pepsinogens as a screening test of extensive chronic gastritis
21. Prevalence of precancerous lesions of the stomach in Venezuela
22. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
23. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer
24. Long term serological surveillance after treatment of Helicobacter pylori infection
25. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori
26. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma